» Articles » PMID: 21378310

RNF41 (Nrdp1) Controls Type 1 Cytokine Receptor Degradation and Ectodomain Shedding

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2011 Mar 8
PMID 21378310
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Cytokines, such as interferons, erythropoietin, leptin and most interleukins, signal through type 1 cytokine receptors and activate the canonical JAK-STAT pathway. Aberrant cytokine signalling underlies numerous pathologies and adequate, temporary receptor activation is therefore under tight control. Negative-feedback mechanisms are very well studied, but cellular sensitivity also depends on the number of receptors exposed at the cell surface. This is determined by the equilibrium between receptor synthesis and transport to the plasma membrane, internalisation and recycling, degradation and ectodomain shedding, but the molecular basis of how cells establish steady state receptor levels is poorly understood. Here, we report that ring finger protein 41 (RNF41, also known as E3 ubiquitin-protein ligase Nrdp1) interacts with JAK2-associated cytokine receptor complexes and modulates their cell surface exposure and signalling. Moreover, ectopic expression of RNF41 affected turnover of leptin, leukaemia inhibitory factor and interleukin-6 receptor in a dual way: it blocked intracellular cathepsin-L-dependent receptor cleavage and concomitantly enhanced receptor shedding by metalloproteases of the ADAM family. Receptor degradation and shedding are thus interconnected phenomena with a single protein, RNF41, determining the balance.

Citing Articles

RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration.

Moreno-Lanceta A, Medrano-Bosch M, Fundora Y, Perramon M, Aspas J, Parra-Robert M Sci Transl Med. 2023; 15(704):eabq6225.

PMID: 37437019 PMC: 10712730. DOI: 10.1126/scitranslmed.abq6225.


Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection.

Urbiola-Salvador V, Lima de Souza S, Gresner P, Qureshi T, Chen Z Int J Mol Sci. 2023; 24(7).

PMID: 37047248 PMC: 10093853. DOI: 10.3390/ijms24076276.


Leptin-Activity Modulators and Their Potential Pharmaceutical Applications.

Greco M, De Santo M, Comande A, Belsito E, Ando S, Liguori A Biomolecules. 2021; 11(7).

PMID: 34356668 PMC: 8301849. DOI: 10.3390/biom11071045.


Chrom-Lasso: a lasso regression-based model to detect functional interactions using Hi-C data.

Lu J, Wang X, Sun K, Lan X Brief Bioinform. 2021; 22(6).

PMID: 34013331 PMC: 8574949. DOI: 10.1093/bib/bbab181.


Comprehensive Analysis of Differentially Expressed lncRNA, circRNA and mRNA and Their ceRNA Networks in Mice With Severe Acute Pancreatitis.

Wang B, Wu J, Huang Q, Yuan X, Yang Y, Jiang W Front Genet. 2021; 12:625846.

PMID: 33584827 PMC: 7876390. DOI: 10.3389/fgene.2021.625846.


References
1.
Royer Y, Staerk J, Costuleanu M, Courtoy P, Constantinescu S . Janus kinases affect thrombopoietin receptor cell surface localization and stability. J Biol Chem. 2005; 280(29):27251-61. DOI: 10.1074/jbc.M501376200. View

2.
Irandoust M, Aarts L, Roovers O, Gits J, Erkeland S, Touw I . Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J. 2007; 26(7):1782-93. PMC: 1847666. DOI: 10.1038/sj.emboj.7601640. View

3.
Hicke L, Dunn R . Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol. 2003; 19:141-72. DOI: 10.1146/annurev.cellbio.19.110701.154617. View

4.
dAzzo A, Bongiovanni A, Nastasi T . E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic. 2005; 6(6):429-41. DOI: 10.1111/j.1600-0854.2005.00294.x. View

5.
Belouzard S, Delcroix D, Rouille Y . Low levels of expression of leptin receptor at the cell surface result from constitutive endocytosis and intracellular retention in the biosynthetic pathway. J Biol Chem. 2004; 279(27):28499-508. DOI: 10.1074/jbc.M400508200. View